150 related articles for article (PubMed ID: 15812226)
1. Low-dose adenoviral immunotherapy of rat hepatocellular carcinoma using single-chain interleukin-12.
Waehler R; Ittrich H; Mueller L; Krupski G; Ameis D; Schnieders F
Hum Gene Ther; 2005 Mar; 16(3):307-17. PubMed ID: 15812226
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of hepatocellular carcinoma by transfecting interleukin-12 and interleukin-2 fusion gene intrasplenically, an experimental study].
Yang JH; Fan RF; Qian QJ; You TG; Xue HB; Su CQ; Cao HF; Wu MC
Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):740-3. PubMed ID: 12899748
[TBL] [Abstract][Full Text] [Related]
3. IL-12 gene therapy is an effective therapeutic strategy for hepatocellular carcinoma in immunosuppressed mice.
Harada N; Shimada M; Okano S; Suehiro T; Soejima Y; Tomita Y; Maehara Y
J Immunol; 2004 Dec; 173(11):6635-44. PubMed ID: 15557154
[TBL] [Abstract][Full Text] [Related]
4. Adenovirus-mediated CD40 ligand gene therapy in a rat model of orthotopic hepatocellular carcinoma.
Schmitz V; Barajas M; Wang L; Peng D; Duarte M; Prieto J; Qian C
Hepatology; 2001 Jul; 34(1):72-81. PubMed ID: 11431736
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy of murine hepatocellular carcinoma by alpha-fetoprotein DNA vaccination combined with adenovirus-mediated chemokine and cytokine expression.
RodrÃguez MM; Ryu SM; Qian C; Geissler M; Grimm C; Prieto J; Blum HE; Mohr L
Hum Gene Ther; 2008 Jul; 19(7):753-9. PubMed ID: 18549308
[TBL] [Abstract][Full Text] [Related]
6. Combined GM-CSF and IL-12 gene therapy synergistically suppresses the growth of orthotopic liver tumors.
Chang CJ; Chen YH; Huang KW; Cheng HW; Chan SF; Tai KF; Hwang LH
Hepatology; 2007 Mar; 45(3):746-54. PubMed ID: 17326190
[TBL] [Abstract][Full Text] [Related]
7. Gene therapy of a rat follicular thyroid carcinoma model with adenoviral vectors transducing murine interleukin-12.
Zhang R; DeGroot LJ
Endocrinology; 2003 Apr; 144(4):1393-8. PubMed ID: 12639922
[TBL] [Abstract][Full Text] [Related]
8. Short-term intratumoral interleukin-12 expressed from an alphaviral vector is sufficient to induce an efficient antitumoral response against spontaneous hepatocellular carcinomas.
Rodriguez-Madoz JR; Zabala M; Alfaro M; Prieto J; Kramer MG; Smerdou C
Hum Gene Ther; 2014 Feb; 25(2):132-43. PubMed ID: 24219025
[TBL] [Abstract][Full Text] [Related]
9. Gene therapy of anaplastic thyroid carcinoma with a single-chain interleukin-12 fusion protein.
Shi Y; Parhar RS; Zou M; Baitei E; Kessie G; Farid NR; Alzahrani A; Al-Mohanna FA
Hum Gene Ther; 2003 Dec; 14(18):1741-51. PubMed ID: 14670125
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of interleukin-12 gene-based tumor immunotherapy by the reduced secretion of p40 subunit and the combination with farnesyltransferase inhibitor.
Jin HT; Youn JI; Kim HJ; Lee JB; Ha SJ; Koh JS; Sung YC
Hum Gene Ther; 2005 Mar; 16(3):328-38. PubMed ID: 15812228
[TBL] [Abstract][Full Text] [Related]
11. A single intratumoral injection of a fiber-mutant adenoviral vector encoding interleukin 12 induces remarkable anti-tumor and anti-metastatic activity in mice with Meth-A fibrosarcoma.
Gao JQ; Sugita T; Kanagawa N; Iida K; Eto Y; Motomura Y; Mizuguchi H; Tsutsumi Y; Hayakawa T; Mayumi T; Nakagawa S
Biochem Biophys Res Commun; 2005 Mar; 328(4):1043-50. PubMed ID: 15707983
[TBL] [Abstract][Full Text] [Related]
12. [Gene transfer of murine Flt3 ligand mediated by adenoviral vector efficiently induces growth inhibition of murine liver cancer].
Yang Q; Yang G; Wei L; Jia F; Wu M; Guo Y
Zhonghua Yi Xue Za Zhi; 2002 Jun; 82(11):775-9. PubMed ID: 12126551
[TBL] [Abstract][Full Text] [Related]
13. Concurrent delivery of GM-CSF and endostatin genes by a single adenoviral vector provides a synergistic effect on the treatment of orthotopic liver tumors.
Tai KF; Chen PJ; Chen DS; Hwang LH
J Gene Med; 2003 May; 5(5):386-98. PubMed ID: 12731087
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus-interleukin-12-mediated tumor regression in a murine hepatocellular carcinoma model is not dependent on CD1-restricted natural killer T cells.
Andrews KJ; Ribas A; Butterfield LH; Vollmer CM; Eilber FC; Dissette VB; Nelson SD; Shintaku P; Mekhoubad S; Nakayama T; Taniguchi M; Glaspy JA; McBride WH; Economou JS
Cancer Res; 2000 Nov; 60(22):6457-64. PubMed ID: 11103813
[TBL] [Abstract][Full Text] [Related]
15. Regional treatment of hepatic micrometastasis by adenovirus vector-mediated delivery of interleukin-2 and interleukin-12 cDNAs to the hepatic parenchyma.
Hirschowitz EA; Naama HA; Evoy D; Lieberman MD; Daly J; Crystal RG
Cancer Gene Ther; 1999; 6(6):491-8. PubMed ID: 10608345
[TBL] [Abstract][Full Text] [Related]
16. Recombinant adenoviral vectors have adjuvant activity and stimulate T cell responses against tumor cells.
Geutskens SB; van der Eb MM; Plomp AC; Jonges LE; Cramer SJ; Ensink NG; Kuppen PJ; Hoeben RC
Gene Ther; 2000 Aug; 7(16):1410-6. PubMed ID: 10981668
[TBL] [Abstract][Full Text] [Related]
17. Effective antitumour mono- and combination therapy by gene delivery of angiostatin-like molecule and interleukin-12 in a murine hepatoma model.
Schmitz V; Tirado-Ledo L; Raskopf E; Rabe C; Wernert N; Wang L; Prieto J; Qian C; Sauerbruch T; Caselmann WH
Int J Colorectal Dis; 2005 Nov; 20(6):494-501. PubMed ID: 15864607
[TBL] [Abstract][Full Text] [Related]
18. Intratumoral coinjection of adenoviral vectors expressing IL-2 and IL-12 results in enhanced frequency of regression of injected and untreated distal tumors.
Addison CL; Bramson JL; Hitt MM; Muller WJ; Gauldie J; Graham FL
Gene Ther; 1998 Oct; 5(10):1400-9. PubMed ID: 9930346
[TBL] [Abstract][Full Text] [Related]
19. Intratumoral delivery of adenovirus-mediated interleukin-12 gene in mice with metastatic cancer in the liver.
Sung MW; Chen SH; Thung SN; Zhang DY; Huang TG; Mandeli JP; Woo SL
Hum Gene Ther; 2002 Apr; 13(6):731-43. PubMed ID: 11936972
[TBL] [Abstract][Full Text] [Related]
20. Adenoviral vectors expressing lymphotactin and interleukin 2 or lymphotactin and interleukin 12 synergize to facilitate tumor regression in murine breast cancer models.
Emtage PC; Wan Y; Hitt M; Graham FL; Muller WJ; Zlotnik A; Gauldie J
Hum Gene Ther; 1999 Mar; 10(5):697-709. PubMed ID: 10210138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
